The global at-home drug of abuse (DOA) market is anticipated to grow at 9.6% CAGR owing to the rising use of illegal drugs like marijuana, cocaine, etc., among teenagers, increasing initiatives by the government to reduce the drug abuse levels, growing production of synthetic cannabinoids, bath salts will propel the growth of the global at-home drug of abuse (DOA) market.

Moreover, the mounting overdose of prescribed drugs and their diagnosis and metabolites will further drive the growth of the global at-home drug of abuse (DOA) market. Developed countries like the US have mandated laws for drug abuse and have allowed legal action against addicts and abusers so as to limit violence and accidents.
The COVID-19 outbreak has disrupted the supply chain and the non-availability of raw material has hindered the production and sales of drug abuse testing equipment and tools.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/at-home-drug-of-abuse-market/request-sample

Based on the sample, the urine samples accounted for a significant share over the projected period owing to its ease and affordability. The key advantage of the test will determine that a particular drug has been used in the past few weeks or days, even though the effects of using the drugs have been worn out.

North America dominates the At-Home Drug of Abuse market owing to the rising number of individuals suffering from substance abuse or alcohol addiction. The increased contribution is due to the adaptation of technologically innovative products for drug abuse testing, augmented demand for illicit drugs in the region, large-scale drug trafficking, that will propel the growth of the At-Home Drug of Abuse market in the region.

In 2019, Abbott has launched a novel hand-held oral fluid drug test SoToxa™ Mobile Test System that can produce results in 5 minutes and mitigate drug-impaired driving. It is light in weight, compact, and easy to use device that can screen rapidly.

The prominent players in the At-Home Drug of Abuse industry include UCP Biosciences Inc. Assure Tech Co. Ltd., Home Health Ltd., Orient New Life Medical Co. Ltd., Confirm BioSciences, Abbott Laboratories, and Psychemedics Corporation.

Source: VynZ Research